Abstract:ABSTRACT Streptomyces coelicolor CR1 ( Sc CR1) has been shown to be a promising biocatalyst for the synthesis of an atorvastatin precursor, ethyl-( S )-4-chloro-3-hydroxybutyrate [( S )-CHBE]. However, limitations of Sc CR1 observed for practical application include low activity and poor stability. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. First, the crystal structure of Sc CR1 complexed with NADH and cosubstrate 2-propanol was solved, and the specific activity of Sc CR1 was increased from 38.8 U/mg to 168 U/mg ( Sc CR1 I158V/P168S ) by structure-guided engineering. Second, directed evolution was performed to improve the stability using Sc CR1 I158V/P168S as a template, affording a triple mutant, Sc CR1 A60T/I158V/P168S , whose thermostability ( T 50 15 , defined as the temperature at which 50% of initial enzyme activity is lost following a heat treatment for 15 min) and substrate tolerance ( C 50 15 , defined as the concentration at which 50% of initial enzyme activity is lost following incubation for 15 min) were 6.2°C and 4.7-fold higher than those of the wild-type enzyme. Interestingly, the specific activity of the triple mutant was further increased to 260 U/mg. Protein modeling and docking analysis shed light on the origin of the improved activity and stability. In the asymmetric reduction of ethyl-4-chloro-3-oxobutyrate (COBE) on a 300-ml scale, 100 g/liter COBE could be completely converted by only 2 g/liter of lyophilized Sc CR1 A60T/I158V/P168S within 9 h, affording an excellent enantiomeric excess ( ee ) of >99% and a space-time yield of 255 g liter −1 day −1 . These results suggest high efficiency of the protein engineering strategy and good potential of the resulting variant for efficient synthesis of the atorvastatin precursor. IMPORTANCE Application of the carbonyl reductase Sc CR1 in asymmetrically synthesizing ( S )-CHBE, a key precursor for the blockbuster drug Lipitor, from COBE has been hindered by its low catalytic activity and poor thermostability and substrate tolerance. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. The catalytic efficiency, thermostability, and substrate tolerance of Sc CR1 were significantly improved by structure-guided engineering and directed evolution. The engineered Sc CR1 may serve as a promising biocatalyst for the biosynthesis of ( S )-CHBE, and the protein engineering strategy adopted in this work would serve as a useful approach for future engineering of other reductases toward potential application in organic synthesis.

Directed evolution of a carbonyl reductase LsCR for the enantioselective synthesis of (1S)-2-chloro-1-(3,4-difluorophenyl) ethanol

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

Engineering the Activity of Old Yellow Enzyme NemR-PS for Efficient Reduction of (<i>E</i>/<i>Z</i>)-Citral to (<i>S</i>)-Citronellol

Semi-rational Design of Carbonyl Reductase Cat for Synthesis of (R)-Lipoic Acid Precursor

Efficient Synthesis of (R)‐2‐Chloro‐1‐(2,4‐dichlorophenyl)ethanol with a Ketoreductase from Scheffersomyces stipitis CBS 6045

Computer‐directed rational design enhanced the thermostability of carbonyl reductase LsCR for the synthesis of ticagrelor precursor

Directed Evolution of Mandelate Racemase by a Novel High-Throughput Screening Method

Significantly Enhancing the Biocatalytic Synthesis of Chiral Alcohols by Semi-Rationally Engineering an Anti-Prelog Carbonyl Reductase from Acetobacter Sp. CCTCC M209061

Gene Hunting and Semi-Rational Design of Carbonyl Reductase from Kosakonia Radicincitans for Highly Efficient Synthesis of the Key Chiral Intermediate of Telotristat Ethyl

Enantioselective Synthesis of Structurally Diverse Aryl Γ-/Δ- Lactones Using an Engineered Carbonyl Reductase

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

Development of an Engineered Ketoreductase with Improved Activity, Stereoselectivity and Relieved Substrate Inhibition for Enantioselective Synthesis of a Key (R)-Α-lipoic Acid Precursor

Engineering a Carbonyl Reductase as a Potential Tool for the Synthesis of Chiral α‐Tetralinols

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Engineering of Carbonyl Reductase for Asymmetric Reduction of Difficult-to-reduce Ketone Tetrahydrofuran-3-one

Selective transformation of crocin-1 to crocetin-glucosyl esters by β-glucosidase (Lf18920) from Leifsonia sp. ZF2019: Insights from molecular docking and point mutations

Engineering carbonyl reductase for one-pot chemobiocatalytic enantioselective synthesis of value-added N-containing chiral alcohol from N-acetyl-D-glucosamine

Engineering Streptomyces Coelicolor Carbonyl Reductase for Efficient Atorvastatin Precursor Synthesis

Carbonyl Reductase Identification and Development of Whole-Cell Biotransformation for Highly Efficient Synthesis of (R)-[3,5-bis(trifluoromethyl)phenyl] Ethanol

Rational design of the carbonyl reductase EbSDR8 for efficient biosynthesis of enantiopure (R)-3-chloro-1-phenyl-1-propanol